Friday, October 17, 2025
5:15 PM – 5:30 PM: Registration
5:30 PM – 6:30 PM: Dinner and CME Presentation
Hyatt Regency Orlando
9801 International Drive
Orlando, FL 32819
Meeting Room: Manatee Spring 1 (Lobby Level)
PROGRAM FEATURES
- An intimate learning opportunity presented by members of our Vision RELIEF Scientific Council
- Downloadable animations, education, and practice aids
- 1.0 CE Credit
PRESENTING FACULTY
 |
Judy E. Kim MD, FARVO, FASRS Jean and Tom Walter Distinguished Chair in Ophthalmology Professor of Ophthalmology Vice Chair of Education Medical Director of Clinical Research UT Southwestern Medical Center Dallas, Texas |
 |
Rishi P. Singh, MD, FASRS Chair, Mass Eye and Ear Mass General Brigham Boston, MA |
PROGRAM OVERVIEW
Join our exclusive, small-group symposia designed for healthcare professionals who provide care for patients with retinal disorders. These sessions explore the evolving role of second-generation anti-VEGF therapies in managing patients with DR/DME. Through real-world clinical cases and interactive, small-group breakout discussions, participants will examine patient selection, treatment planning, and strategies to optimize durability and clinical outcomes. Led by expert faculty, each symposium fosters peer-to-peer collaboration and delivers practical insights for integrating these therapies into clinical practice. The intimate setting encourages meaningful exchange and focused learning. Don’t miss this opportunity to advance your expertise at these unique educational events.
LEARNING OBJECTIVES
- Evaluate the latest evidence with second-generation anti-VEGF agents for DR and DME, as well as how their efficacy, safety, and durability address current barriers to care and reduces treatment burden
- Design individualized treatment strategies that incorporate patient factors and current real-world and clinical trial data on efficacy and safety of second-generation agents to minimize treatment burden and optimize visual outcomes for patients with DR and DME
TARGET AUDIENCE
This is designed to meet the educational needs of retina specialists and comprehensive ophthalmologists involved in the management of patients with retinal disease.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team..
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
